{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:34Z","timestamp":1791928714724,"version":"4.3.4"},"reference-count":68,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"14","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2019,11,4]]},"DOI":"10.1167\/iovs.18-25502","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T13:30:54Z","timestamp":1572874254000},"page":"4632","source":"Crossref","is-referenced-by-count":12,"title":["Propranolol Attenuates Proangiogenic Activity of Mononuclear Phagocytes: Implication in Choroidal Neovascularization"],"prefix":"10.1167","volume":"60","author":[{"given":"Samy","family":"Omri","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Center, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Tahiri","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Maisonneuve-Rosemont Hospital Research Center, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyston Chadwick","family":"Pierre","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Sainte-Justine Hospital Research Center, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Desjarlais","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Maisonneuve-Rosemont Hospital Research Center, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lahaie","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Center, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Eve","family":"Loiselle","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Sainte-Justine Hospital Research Center, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Rezende","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Center, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Lodygensky","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Sainte-Justine Hospital Research Center, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence E.","family":"Hebert","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Therapeutics, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Ong","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Universit\u00e9 de Montr\u00e9al, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Chemtob","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Center, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"},{"name":"Department of Pediatrics, Universit\u00e9 de Montr\u00e9al, Montreal, Canada"},{"name":"Department of Ophthalmology, Universit\u00e9 de Montr\u00e9al, Montreal, Canada"},{"name":"Department of Pharmacology, Universit\u00e9 de Montr\u00e9al, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-60-14-4632-b01","doi-asserted-by":"crossref","unstructured":"Schlingemann RO. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2004; 242: 91\u2013101.","DOI":"10.1007\/s00417-003-0828-0"},{"key":"i1552-5783-60-14-4632-b02","doi-asserted-by":"crossref","unstructured":"Bhutto IA, McLeod DS, Hasegawa T, et al. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res. 2006; 82: 99\u2013110.","DOI":"10.1016\/j.exer.2005.05.007"},{"key":"i1552-5783-60-14-4632-b03","unstructured":"Lu M, Adamis AP. Molecular biology of choroidal neovascularization. Ophthalmol Clin North Am. 2006; 19: 323\u2013334."},{"key":"i1552-5783-60-14-4632-b04","doi-asserted-by":"crossref","unstructured":"Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008; 358: 2649\u20132651.","DOI":"10.1056\/NEJMc0708819"},{"key":"i1552-5783-60-14-4632-b05","doi-asserted-by":"crossref","unstructured":"Pan WK, Li P, Guo ZT, Huang Q, Gao Y. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K\/Akt\/eNOS\/VEGF pathway. Pediatr Blood Cancer. 2015; 62: 1414\u20131420.","DOI":"10.1002\/pbc.25453"},{"key":"i1552-5783-60-14-4632-b06","unstructured":"Elena PP, Kosina-Boix M, Moulin G, Lapalus P. Autoradiographic localization of beta-adrenergic receptors in rabbit eye. Invest Ophthalmol Vis Sci. 1987; 28: 1436\u20131441."},{"key":"i1552-5783-60-14-4632-b07","doi-asserted-by":"crossref","unstructured":"Lashbrook BL, Steinle JJ. Beta-adrenergic receptor regulation of pigment epithelial-derived factor expression in rat retina. Auton Neurosci. 2005; 121: 33\u201339.","DOI":"10.1016\/j.autneu.2005.05.006"},{"key":"i1552-5783-60-14-4632-b08","doi-asserted-by":"crossref","unstructured":"Lavine JA, Sang Y, Wang S, Ip MS, Sheibani N. Attenuation of choroidal neovascularization by beta(2)-adrenoreceptor antagonism. JAMA Ophthalmol. 2013; 131: 376\u2013382.","DOI":"10.1001\/jamaophthalmol.2013.1476"},{"key":"i1552-5783-60-14-4632-b09","doi-asserted-by":"crossref","unstructured":"Lavine JA, Farnoodian M, Wang S, et al. Beta2-adrenergic receptor antagonism attenuates CNV through inhibition of VEGF and IL-6 expression. Invest Ophthalmol Vis Sci. 2017; 58: 299\u2013308.","DOI":"10.1167\/iovs.16-20204"},{"key":"i1552-5783-60-14-4632-b10","doi-asserted-by":"crossref","unstructured":"Nourinia R, Rezaei Kanavi M, Kaharkaboudi A, et al. Ocular Safety of intravitreal propranolol and its efficacy in attenuation of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2015; 56: 8228\u20138235.","DOI":"10.1167\/iovs.15-17169"},{"key":"i1552-5783-60-14-4632-b11","doi-asserted-by":"crossref","unstructured":"Przewratil P, Kobos J, Wnek A, et al. Serum and tissue profile of VEGF and its receptors VGFR1\/R2 in children with infantile hemangiomas on systemic propranolol treatment. Immunol Lett. 2016; 175: 44\u201349.","DOI":"10.1016\/j.imlet.2016.05.002"},{"key":"i1552-5783-60-14-4632-b12","doi-asserted-by":"crossref","unstructured":"Babiak-Choroszczak L, Gizewska-Kacprzak K, Gawrych E, et al. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas? Adv Clin Exp Med. 2018; 27: 703\u2013710.","DOI":"10.17219\/acem\/84800"},{"key":"i1552-5783-60-14-4632-b13","doi-asserted-by":"crossref","unstructured":"Wnek A, Andrzejewska E, Kobos J, Taran K, Przewratil P. Molecular and immunohistochemical expression of apoptotic proteins Bax, Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment. Immunol Lett. 2017; 185: 27\u201331.","DOI":"10.1016\/j.imlet.2017.03.005"},{"key":"i1552-5783-60-14-4632-b14","unstructured":"Grossniklaus HE, Ling JX, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis. 2002; 8: 119\u2013126."},{"key":"i1552-5783-60-14-4632-b15","doi-asserted-by":"crossref","unstructured":"Chung ES, Chauhan SK, Jin Y, et al. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol. 2009; 175: 1984\u20131992.","DOI":"10.2353\/ajpath.2009.080515"},{"key":"i1552-5783-60-14-4632-b16","doi-asserted-by":"crossref","unstructured":"Barbay V, Houssari M, Mekki M, et al. Role of M2-like macrophage recruitment during angiogenic growth factor therapy. Angiogenesis. 2015; 18: 191\u2013200.","DOI":"10.1007\/s10456-014-9456-z"},{"key":"i1552-5783-60-14-4632-b17","doi-asserted-by":"crossref","unstructured":"Tahiri H, Omri S, Yang C, et al. Lymphocytic microparticles modulate angiogenic properties of macrophages in laser-induced choroidal neovascularization. Sci Rep. 2016; 6: 37391.","DOI":"10.1038\/srep37391"},{"key":"i1552-5783-60-14-4632-b18","doi-asserted-by":"crossref","unstructured":"Eslani M, Putra I, Shen X, et al. Cornea-derived mesenchymal stromal cells therapeutically modulate macrophage immunophenotype and angiogenic function. Stem Cells. 2018; 36: 775\u2013784.","DOI":"10.1002\/stem.2781"},{"key":"i1552-5783-60-14-4632-b19","unstructured":"Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1999; 40: 1891\u20131898."},{"key":"i1552-5783-60-14-4632-b20","doi-asserted-by":"crossref","unstructured":"Espinosa-Heidmann DG, Caicedo A, Hernandez EP, Csaky KG, Cousins SW. Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003; 44: 4914\u20134919.","DOI":"10.1167\/iovs.03-0371"},{"key":"i1552-5783-60-14-4632-b21","doi-asserted-by":"crossref","unstructured":"Weber ML, Heier JS. Choroidal neovascularization secondary to myopia, infection and inflammation. Dev Ophthalmol. 2016; 55: 167\u2013175.","DOI":"10.1159\/000431194"},{"key":"i1552-5783-60-14-4632-b22","doi-asserted-by":"crossref","unstructured":"Izeboud CA, Mocking JA, Monshouwer M, van Miert AS, Witkamp RF. Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J Recept Signal Transduct Res. 1999; 19: 191\u2013202.","DOI":"10.3109\/10799899909036645"},{"key":"i1552-5783-60-14-4632-b23","doi-asserted-by":"crossref","unstructured":"Yang Y, Liu F, Tang M, et al. Macrophage polarization in experimental and clinical choroidal neovascularization. Sci Rep. 2016; 6: 30933.","DOI":"10.1038\/srep30933"},{"key":"i1552-5783-60-14-4632-b24","doi-asserted-by":"crossref","unstructured":"Tan X, Fujiu K, Manabe I, et al. Choroidal neovascularization is inhibited in splenic-denervated or splenectomized mice with a concomitant decrease in intraocular macrophage. PLoS One. 2016; 11: e0160985.","DOI":"10.1371\/journal.pone.0160985"},{"key":"i1552-5783-60-14-4632-b25","unstructured":"Wang N, Koutz CA, Anderson RE. A method for the isolation of retinal pigment epithelial cells from adult rats. Invest Ophthalmol Vis Sci. 1993; 34: 101\u2013107."},{"key":"i1552-5783-60-14-4632-b26","doi-asserted-by":"crossref","unstructured":"Tahiri H, Yang C, Duhamel F, et al. p75 neurotrophin receptor participates in the choroidal antiangiogenic and apoptotic effects of T-lymphocyte-derived microparticles. Invest Ophthalmol Vis Sci. 2013; 54: 6084\u20136092.","DOI":"10.1167\/iovs.13-11896"},{"key":"i1552-5783-60-14-4632-b27","doi-asserted-by":"crossref","unstructured":"Omri S, Behar-Cohen F, de Kozak Y, et al. Microglia\/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCzeta in the Goto Kakizaki rat model. Am J Pathol. 2011; 179: 942\u2013953.","DOI":"10.1016\/j.ajpath.2011.04.018"},{"key":"i1552-5783-60-14-4632-b28","doi-asserted-by":"crossref","unstructured":"Ogata A, Chauhan D, Teoh G, et al. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. J Immunol. 1997; 159: 2212\u20132221.","DOI":"10.4049\/jimmunol.159.5.2212"},{"key":"i1552-5783-60-14-4632-b29","doi-asserted-by":"crossref","unstructured":"Iankov I, Praskova M, Kalenderova S, Tencheva Z, Mitov I, Mitev V. The effect of chemical blockade of PKC with Go6976 and Go6983 on proliferation and MAPK activity in IL-6-dependent plasmacytoma cells. Leuk Res. 2002; 26: 363\u2013368.","DOI":"10.1016\/S0145-2126(01)00132-1"},{"key":"i1552-5783-60-14-4632-b30","doi-asserted-by":"crossref","unstructured":"Markomichelakis NN, Theodossiadis PG, Sfikakis PP. Regression of neovascular age-related macular degeneration following infliximab therapy. Am J Ophthalmol. 2005; 139: 537\u2013540.","DOI":"10.1016\/j.ajo.2004.09.058"},{"key":"i1552-5783-60-14-4632-b31","doi-asserted-by":"crossref","unstructured":"Ripperger J, Fritz S, Richter K, et al. Isolation of two interleukin-6 response element binding proteins from acute phase rat livers. Ann N Y Acad Sci. 1995; 762: 252\u2013260; discussion 260\u2013261.","DOI":"10.1111\/j.1749-6632.1995.tb32330.x"},{"key":"i1552-5783-60-14-4632-b32","doi-asserted-by":"crossref","unstructured":"Alonzi T, Fattori E, Cappelletti M, Ciliberto G, Poli V. Impaired Stat3 activation following localized inflammatory stimulus in IL-6-deficient mice. Cytokine. 1998; 10: 13\u201318.","DOI":"10.1006\/cyto.1997.0250"},{"key":"i1552-5783-60-14-4632-b33","doi-asserted-by":"crossref","unstructured":"Abrass CK, O'Connor SW, Scarpace PJ, Abrass IB. Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J Immunol. 1985; 135: 1338\u20131341.","DOI":"10.4049\/jimmunol.135.2.1338"},{"key":"i1552-5783-60-14-4632-b34","doi-asserted-by":"crossref","unstructured":"Wirth JJ, Kierszenbaum F. Inhibitory action of elevated levels of adenosine-3':5' cyclic monophosphate on phagocytosis: effects on macrophage-Trypanosoma cruzi interaction. J Immunol. 1982; 129: 2759\u20132762.","DOI":"10.4049\/jimmunol.129.6.2759"},{"key":"i1552-5783-60-14-4632-b35","doi-asserted-by":"crossref","unstructured":"Borda ES, Tenenbaum A, Sales ME, Rumi L, Sterin-Borda L. Role of arachidonic acid metabolites in the action of a beta adrenergic agonist on human monocyte phagocytosis. Prostaglandins Leukot Essent Fatty Acids. 1998; 58: 85\u201390.","DOI":"10.1016\/S0952-3278(98)90145-4"},{"key":"i1552-5783-60-14-4632-b36","doi-asserted-by":"crossref","unstructured":"Hasko G, Szabo C, Nemeth ZH, Deitch EA. Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. J Neuroimmunol. 2002; 122: 34\u201339.","DOI":"10.1016\/S0165-5728(01)00459-3"},{"key":"i1552-5783-60-14-4632-b37","doi-asserted-by":"crossref","unstructured":"Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999; 285: 245\u2013248.","DOI":"10.1126\/science.285.5425.245"},{"key":"i1552-5783-60-14-4632-b38","doi-asserted-by":"crossref","unstructured":"Li M, Chen Y, Guo Z, et al. The pigment epithelium-derived factor (PEDF): an important potential therapeutic agent for infantile hemangioma. Arch Dermatol Res. 2017; 309: 169\u2013178.","DOI":"10.1007\/s00403-017-1716-5"},{"key":"i1552-5783-60-14-4632-b39","doi-asserted-by":"crossref","unstructured":"Schuller HM, Cole B. Regulation of cell proliferation by beta-adrenergic receptors in a human lung adenocarcinoma cell line. Carcinogenesis. 1989; 10: 1753\u20131755.","DOI":"10.1093\/carcin\/10.9.1753"},{"key":"i1552-5783-60-14-4632-b40","doi-asserted-by":"crossref","unstructured":"Stiles J, Amaya C, Pham R, et al. Propranolol treatment of infantile hemangioma endothelial cells: a molecular analysis. Exp Ther Med. 2012; 4: 594\u2013604.","DOI":"10.3892\/etm.2012.654"},{"key":"i1552-5783-60-14-4632-b41","doi-asserted-by":"crossref","unstructured":"Buckmiller LM. Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg. 2009; 17: 458\u2013459.","DOI":"10.1097\/MOO.0b013e328332a4eb"},{"key":"i1552-5783-60-14-4632-b42","doi-asserted-by":"crossref","unstructured":"Shaw PX, Zhang L, Zhang M, et al. Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids. Proc Natl Acad Sci U S A. 2012; 109: 13757\u201313762.","DOI":"10.1073\/pnas.1121309109"},{"key":"i1552-5783-60-14-4632-b43","doi-asserted-by":"crossref","unstructured":"Lu Z, Lin V, May A, et al. HTRA1 synergizes with oxidized phospholipids in promoting inflammation and macrophage infiltration essential for ocular VEGF expression. PLoS One. 2019; 14: e0216808.","DOI":"10.1371\/journal.pone.0216808"},{"key":"i1552-5783-60-14-4632-b44","doi-asserted-by":"crossref","unstructured":"Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003; 44: 3578\u20133585.","DOI":"10.1167\/iovs.03-0097"},{"key":"i1552-5783-60-14-4632-b45","doi-asserted-by":"crossref","unstructured":"Apte RS, Richter J, Herndon J, Ferguson TA. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med. 2006; 3: e310.","DOI":"10.1371\/journal.pmed.0030310"},{"key":"i1552-5783-60-14-4632-b46","unstructured":"Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014; 6: 13."},{"key":"i1552-5783-60-14-4632-b47","doi-asserted-by":"crossref","unstructured":"Bertani FR, Mozetic P, Fioramonti M, et al. Classification of M1\/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis. Sci Rep. 2017; 7: 8965.","DOI":"10.1038\/s41598-017-08121-8"},{"key":"i1552-5783-60-14-4632-b48","doi-asserted-by":"crossref","unstructured":"Sloan EK, Priceman SJ, Cox BF, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010; 70: 7042\u20137052.","DOI":"10.1158\/0008-5472.CAN-10-0522"},{"key":"i1552-5783-60-14-4632-b49","doi-asserted-by":"crossref","unstructured":"Qin JF, Jin FJ, Li N, et al. Adrenergic receptor beta2 activation by stress promotes breast cancer progression through macrophages M2 polarization in tumor microenvironment. BMB Rep. 2015; 48: 295\u2013300.","DOI":"10.5483\/BMBRep.2015.48.5.008"},{"key":"i1552-5783-60-14-4632-b50","doi-asserted-by":"crossref","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23: 549\u2013555.","DOI":"10.1016\/S1471-4906(02)02302-5"},{"key":"i1552-5783-60-14-4632-b51","unstructured":"Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996; 56: 4625\u20134629."},{"key":"i1552-5783-60-14-4632-b52","doi-asserted-by":"crossref","unstructured":"Bingle L, Lewis CE, Corke KP, Reed MW, Brown NJ. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer. 2006; 94: 101\u2013107.","DOI":"10.1038\/sj.bjc.6602901"},{"key":"i1552-5783-60-14-4632-b53","doi-asserted-by":"crossref","unstructured":"Stein EV, Miller TW, Ivins-O'Keefe K, Kaur S, Roberts DD. Secreted thrombospondin-1 regulates macrophage interleukin-1beta production and activation through CD47. Sci Rep. 2016; 6: 19684.","DOI":"10.1038\/srep19684"},{"key":"i1552-5783-60-14-4632-b54","doi-asserted-by":"crossref","unstructured":"Garcia-Garcia L, Recalde S, Hernandez M, et al. Long-term PEDF release in rat iris and retinal epithelial cells after sleeping beauty transposon-mediated gene delivery. Mol Ther Nucleic Acids. 2017; 9: 1\u201311.","DOI":"10.1016\/j.omtn.2017.08.001"},{"key":"i1552-5783-60-14-4632-b55","doi-asserted-by":"crossref","unstructured":"Lavoie C, Mercier JF, Salahpour A, et al. Beta 1\/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem. 2002; 277: 35402\u201335410.","DOI":"10.1074\/jbc.M204163200"},{"key":"i1552-5783-60-14-4632-b56","doi-asserted-by":"crossref","unstructured":"Breit A, Lagace M, Bouvier M. Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem. 2004; 279: 28756\u201328765.","DOI":"10.1074\/jbc.M313310200"},{"key":"i1552-5783-60-14-4632-b57","unstructured":"Frambach DA, Fain GL, Farber DB, Bok D. Beta adrenergic receptors on cultured human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1990; 31: 1767\u20131772."},{"key":"i1552-5783-60-14-4632-b58","doi-asserted-by":"crossref","unstructured":"Tanaka KF, Kashima H, Suzuki H, Ono K, Sawada M. Existence of functional beta1- and beta2-adrenergic receptors on microglia. J Neurosci Res. 2002; 70: 232\u2013237.","DOI":"10.1002\/jnr.10399"},{"key":"i1552-5783-60-14-4632-b59","doi-asserted-by":"crossref","unstructured":"Walker RJ, Steinle JJ. Role of beta-adrenergic receptors in inflammatory marker expression in M\u00fcller cells. Invest Ophthalmol Vis Sci. 2007; 48: 5276\u20135281.","DOI":"10.1167\/iovs.07-0129"},{"key":"i1552-5783-60-14-4632-b60","doi-asserted-by":"crossref","unstructured":"Gyoneva S, Traynelis SF. Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors. J Biol Chem. 2013; 288: 15291\u201315302.","DOI":"10.1074\/jbc.M113.458901"},{"key":"i1552-5783-60-14-4632-b61","doi-asserted-by":"crossref","unstructured":"Yamawaki T, Ito E, Mukai A, et al. The ingenious interactions between macrophages and functionally plastic retinal pigment epithelium cells. Invest Ophthalmol Vis Sci. 2016; 57: 5945\u20135953.","DOI":"10.1167\/iovs.16-20604"},{"key":"i1552-5783-60-14-4632-b62","doi-asserted-by":"crossref","unstructured":"Steinle JJ, Zamora DO, Rosenbaum JT, Granger HJ. Beta 3-adrenergic receptors mediate choroidal endothelial cell invasion, proliferation, and cell elongation. Exp Eye Res. 2005; 80: 83\u201391.","DOI":"10.1016\/j.exer.2004.08.015"},{"key":"i1552-5783-60-14-4632-b63","unstructured":"Lin X, Luo K, Lv Z, Huang J. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice. Hepatogastroenterology. 2012; 59: 584\u2013588."},{"key":"i1552-5783-60-14-4632-b64","doi-asserted-by":"crossref","unstructured":"Cammalleri M, Locri F, Catalani E, et al. The beta adrenergic receptor blocker propranolol counteracts retinal dysfunction in a mouse model of oxygen induced retinopathy: restoring the balance between apoptosis and autophagy. Front Cell Neurosci. 2017; 11: 395.","DOI":"10.3389\/fncel.2017.00395"},{"key":"i1552-5783-60-14-4632-b65","doi-asserted-by":"crossref","unstructured":"Kaempfen S, Neumann RP, Jost K, Schulzke SM. Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants. Cochrane Database Syst Rev. 2018; 3: CD011893.","DOI":"10.1002\/14651858.CD011893.pub2"},{"key":"i1552-5783-60-14-4632-b66","doi-asserted-by":"crossref","unstructured":"Martini D, Monte MD, Ristori C, et al. Antiangiogenic effects of beta2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy. J Neurochem. 2011; 119: 1317\u20131329.","DOI":"10.1111\/j.1471-4159.2011.07530.x"},{"key":"i1552-5783-60-14-4632-b67","unstructured":"Chidiac P, Hebert TE, Valiquette M, Dennis M, Bouvier M. Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol. 1994; 45: 490\u2013499."},{"key":"i1552-5783-60-14-4632-b68","doi-asserted-by":"crossref","unstructured":"Wrzal PK, Devost D, Petrin D, et al. Allosteric interactions between the oxytocin receptor and the beta2-adrenergic receptor in the modulation of ERK1\/2 activation are mediated by heterodimerization. Cell Signal. 2012; 24: 342\u2013350.","DOI":"10.1016\/j.cellsig.2011.09.020"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2754211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:10Z","timestamp":1791927070000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2754211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":68,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-25502","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,4]]}}}